Statistics for Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study
Total visits
| views | |
|---|---|
| Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study | 158 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| J Acquir Immune Defic Syndr. 2010 Sep 1, 55(1) 49-57.pdf(legacy) | 1581 |
| J Acquir Immune Defic Syndr. 2010 Sep 1, 55(1) 49-57.pdf | 12 |
| lombalgia.pdf(legacy) | 1 |
| Derrame pleural 14Jan2016.pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| United States | 52 |
| China | 28 |
| Portugal | 13 |
| Australia | 10 |
| Russia | 8 |
| France | 7 |
| Romania | 7 |
| Ukraine | 6 |
| Canada | 4 |
| Mexico | 4 |
| Thailand | 2 |
| Argentina | 1 |
| Austria | 1 |
| Brazil | 1 |
| Belarus | 1 |
| Switzerland | 1 |
| Germany | 1 |
| Denmark | 1 |
| United Kingdom | 1 |
| Hong Kong SAR China | 1 |
| India | 1 |
| Italy | 1 |
| Japan | 1 |
| Latvia | 1 |
| Mongolia | 1 |
| Malaysia | 1 |
| Nigeria | 1 |
| Taiwan | 1 |